203 related articles for article (PubMed ID: 30183421)
1. Treating patients with renal cell carcinoma and bone metastases.
Guida A; Escudier B; Albiges L
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1135-1143. PubMed ID: 30183421
[TBL] [Abstract][Full Text] [Related]
2. [Not Available].
Guida A; Albiges L
Bull Cancer; 2018 Dec; 105 Suppl 3():S268-S279. PubMed ID: 30595156
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
[TBL] [Abstract][Full Text] [Related]
4. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.
Kalra S; Verma J; Atkinson BJ; Matin SF; Wood CG; Karam JA; Lin SH; Satcher RL; Tamboli P; Sircar K; Rao P; Corn PG; Tannir NM; Jonasch E
Clin Genitourin Cancer; 2017 Jun; 15(3):363-370. PubMed ID: 28216278
[TBL] [Abstract][Full Text] [Related]
6. Treatment of spinal metastases in renal cell carcinoma: A critical review.
Teyssonneau D; Gross-Goupil M; Domblides C; Haaser T; Pointillart V; Daste A; Hauger O; Ravaud A
Crit Rev Oncol Hematol; 2018 May; 125():19-29. PubMed ID: 29650272
[TBL] [Abstract][Full Text] [Related]
7. Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
Santoni M; Conti A; Procopio G; Porta C; Ibrahim T; Barni S; Guida FM; Fontana A; Berruti A; Berardi R; Massari F; Vincenzi B; Ortega C; Ottaviani D; Carteni G; Lanzetta G; De Lisi D; Silvestris N; Satolli MA; Collovà E; Russo A; Badalamenti G; Luzi Fedeli S; Tanca FM; Adamo V; Maiello E; Sabbatini R; Felici A; Cinieri S; Montironi R; Bracarda S; Tonini G; Cascinu S; Santini D
J Exp Clin Cancer Res; 2015 Feb; 34(1):10. PubMed ID: 25651794
[TBL] [Abstract][Full Text] [Related]
8. Management of Patients With Metastatic Renal Cell Cancer and Bone Metastases.
Nieder C; Dalhaug A; Pawinski AR
In Vivo; 2020; 34(2):675-678. PubMed ID: 32111768
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case report.
Yaegashi H; Izumi K; Konaka H; Mizokami A; Namiki M
J Med Case Rep; 2015 Nov; 9():261. PubMed ID: 26582158
[TBL] [Abstract][Full Text] [Related]
10. Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy.
Kim SH; Park WS; Kim SH; Joung JY; Seo HK; Lee KH; Chung J
Cancer Res Treat; 2016 Jul; 48(3):1092-101. PubMed ID: 26875203
[TBL] [Abstract][Full Text] [Related]
11. An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma.
Grünwald V; Eberhardt B; Bex A; Flörcken A; Gauler T; Derlin T; Panzica M; Dürr HR; Grötz KA; Giles RH; von Falck C; Graser A; Muacevic A; Staehler M
Nat Rev Urol; 2018 Aug; 15(8):511-521. PubMed ID: 29904105
[TBL] [Abstract][Full Text] [Related]
12. Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC).
Brinkmann OA; Bruns F; Prott FJ; Hertle L
Anticancer Res; 1999; 19(2C):1583-7. PubMed ID: 10365150
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Metastatic Renal Cell Carcinoma].
Richter I; Dvořák J
Klin Onkol; 2018; 31(2):110-116. PubMed ID: 29708353
[TBL] [Abstract][Full Text] [Related]
14. Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature.
Hird AE; Chow E; Ehrlich L; Probyn L; Sinclair E; Yip D; Ko YJ
J Palliat Med; 2008 Oct; 11(8):1156-61. PubMed ID: 18980461
[TBL] [Abstract][Full Text] [Related]
15. Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions.
Donini M; Buti S; Massari F; Mollica V; Rizzo A; Montironi R; Bersanelli M; Santoni M
Expert Rev Anticancer Ther; 2020 Jun; 20(6):491-501. PubMed ID: 32479120
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapeutics in refractory renal cell carcinoma.
Koshkin VS; Rini BI
Expert Opin Pharmacother; 2016 Jun; 17(9):1225-32. PubMed ID: 27112171
[TBL] [Abstract][Full Text] [Related]
17. Skeletal metastasis in renal cell carcinoma: current and future management options.
Wood SL; Brown JE
Cancer Treat Rev; 2012 Jun; 38(4):284-91. PubMed ID: 21802857
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sunitinib in patients with renal cell carcinoma with bone metastases.
Paule B; Brion N
Anticancer Res; 2010 Dec; 30(12):5165-8. PubMed ID: 21187506
[TBL] [Abstract][Full Text] [Related]
19. [Systemic therapy approaches in patients with bone metastases of urogenital malignancies].
Finter F; Mottaghy FM; Kuefer R; Hautmann RE; Rinnab L
Urologe A; 2007 Aug; 46(8):904, 906-12. PubMed ID: 17639296
[TBL] [Abstract][Full Text] [Related]
20. Management of metastatic renal cell carcinoma: current trends.
Mohammed A; Shergill I; Little B
Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
